Cancer Immunotherapy: Agilent xCELLigence RTCA handbook
22 Nov 2023In this handbook, Agilent Technologies provides insights into cancer immunotherapy, exploring the strategies employed to harness the immune system for tumor targeting. The guide introduces Agilent xCELLigence real-time cell analysis (RTCA) and its diverse applications in cancer immunotherapy. It details how the xCELLigence RTCA assay works, covering the measurement of cellular impedance with E-Plates and explaining real-time cellular impedance traces.
Related Products
Request Quote for All Products
xCELLigence RTCA DP
Agilent TechnologiesThe Agilent xCELLigence Real-Time Cell Analysis (RTCA) DP (dual purpose) instrument continuously measures cell invasion and migration (CIM) and monitors cell health, behavior, and function using label-free cellular impedance. The three cradles of the DP instrument enable three separate electronic 16-well plates to be controlled and monitored in parallel or independently of one another. This flexible plate batch processing allows maximum productivity for multiple users. The instrument operates in a standard CO2 cell culture incubator and the control unit is housed outside the incubator. Online data acquisition and offline data analysis are easy to perform using RTCA Software Pro, which also supports FDA 21 CFR Part 11 compliance. For Research Use Only. Not for use in diagnostic procedures.